Insight Molecular Diagnostics Inc
Insight Molecular Diagnostics Inc (IMDX) Unusual Options Activity Today
IMDX options volume power reached 0x on the previous trading day. The highest reading was on the $4 CALL expiring 2026-10-16.
Read more
Checking IMDX unusual options activity helps you spot when traders are making outsized bets on Insight Molecular Diagnostics Inc before the broader market catches on. Insight Molecular Diagnostics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor IMDX unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching IMDX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking IMDX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and IMDX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay. It also provides biomarker discovery testing, assay design and development, and clinical trial support services, as well as various biomarker tests for pharmaceutical companies. The company has a collaboration agreement with Life Technologies Corporation to develop and collaborate in the commercialization of Oncomine Comprehensive Assay Plus and Determa IO assay for use with Ion Torrent Genexus integrated sequencer and purification system.
OncoCyte Corporation was incorporated in 2009 and is based in Irvine, California.
Catalysts rarely arrive without a footprint, and IMDX unusual options activity is often where that footprint shows up first. Our scanner tracks Insight Molecular Diagnostics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at IMDX unusual options volume on the call side or chasing put sweeps, Insight Molecular Diagnostics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 1.00 | 0.50 | 4.90 | 2.70 | 957% | 0 | 0 | — |
| 2.00 | — | 4.90 | 4.90 | 1,000% | 0 | 0 | — |
| 3.00 | — | 4.90 | 4.90 | 1,000% | 0 | 0 | — |
| 4.00 | — | 4.90 | 4.90 | 1,000% | 0 | 4 | 0.00% |
| 5.00 | — | 0.10 | 0.10 | 180% | 0 | 9 | 0.00% |
| 4.00 | — | 4.90 | 4.90 | 1,000% | 1 | 14 | 7.14% |
| 1.00 | — | 4.90 | 4.90 | 1,000% | 0 | 0 | — |
| 2.00 | — | 4.90 | 4.90 | 1,000% | 0 | 0 | — |
| 3.00 | — | 0.85 | 0.85 | 356% | 3 | 0 | — |
| 5.00 | — | 4.90 | 4.90 | 1,000% | 0 | 0 | — |
As of September 29, 2026
Spot unusual options activity before it moves
Track IMDX options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→